Yixintang Pharmaceutical (SZ:002727) Xin Lang Cai Jing·2025-11-12 01:59Company Overview - Yunnan Yixintang Pharmaceutical Group Co., Ltd. is located in Kunming, Yunnan Province, and was established on November 8, 2000. The company was listed on July 2, 2014. Its main business involves retail and wholesale of pharmaceuticals, with revenue composition as follows: Western and Chinese medicines 75.03%, others 9.86%, traditional Chinese medicine 8.56%, and medical devices and disinfectants 6.55% [1][2]. Stock Performance - As of November 12, Yixintang's stock price increased by 2.02%, reaching 14.14 CNY per share, with a market capitalization of 8.28 billion CNY. The stock has risen 12.85% year-to-date, with a 5.52% increase over the last five trading days [1]. - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent occurrence on May 23, where it recorded a net buy of -4.0951 million CNY [1]. Financial Performance - For the period from January to September 2025, Yixintang reported a revenue of 13.001 billion CNY, a year-on-year decrease of 4.33%, and a net profit attributable to shareholders of 269 million CNY, down 8.17% year-on-year [2][3]. Shareholder Information - As of September 30, 2025, Yixintang had 37,500 shareholders, an increase of 10.53% from the previous period. The average number of circulating shares per shareholder decreased by 9.53% to 10,596 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 22.3144 million shares, an increase of 3.74 million shares from the previous period. Several new institutional shareholders have entered the top ten list [3]. Dividend Distribution - Since its A-share listing, Yixintang has distributed a total of 2.023 billion CNY in dividends, with 764 million CNY distributed over the past three years [3].